Becker Capital Management Inc. Sells 1,563 Shares of McKesson Corporation $MCK

Becker Capital Management Inc. lowered its stake in shares of McKesson Corporation (NYSE:MCK) by 1.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,395 shares of the company’s stock after selling 1,563 shares during the period. McKesson accounts for about 1.8% of Becker Capital Management Inc.’s investment portfolio, making the stock its 12th biggest holding. Becker Capital Management Inc. owned approximately 0.06% of McKesson worth $61,401,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in MCK. GGM Financials LLC bought a new stake in McKesson during the third quarter valued at about $25,000. State of Wyoming bought a new stake in shares of McKesson in the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. purchased a new position in shares of McKesson in the 3rd quarter worth approximately $31,000. Abound Wealth Management raised its stake in shares of McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after acquiring an additional 24 shares in the last quarter. Finally, Delos Wealth Advisors LLC purchased a new stake in McKesson during the second quarter valued at approximately $35,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MCK has been the subject of several recent analyst reports. Mizuho raised their price target on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Robert W. Baird set a $968.00 price target on shares of McKesson in a research note on Wednesday, January 14th. Wall Street Zen downgraded shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Weiss Ratings downgraded McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $966.00 price target on shares of McKesson in a research report on Thursday, January 29th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $943.50.

McKesson Trading Up 1.0%

MCK stock opened at $984.61 on Monday. McKesson Corporation has a 12-month low of $621.88 and a 12-month high of $987.37. The stock has a market cap of $120.60 billion, a price-to-earnings ratio of 28.32, a PEG ratio of 1.59 and a beta of 0.38. The business’s 50-day moving average is $868.77 and its 200 day moving average is $807.56.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Insider Buying and Selling

In other news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares of the company’s stock, valued at $2,824,605. This represents a 5.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 1,143 shares of company stock worth $1,046,070. 0.08% of the stock is currently owned by corporate insiders.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.